CompanyDrug

Eisai Biogen’s LEQEMBI Subcutaneous Autoinjector Wins NMPA Priority Review in China

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics
CompanyDeals

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics

CompanyDeals

Hemony Pharma Partners with Insud Pharma to Advance Fourth-Generation Oral Contraceptive in China

CompanyDeals

Overseas Pharma Partners with South American Pharma Group on Global Extended-Release Drug Development

CompanyDigital

Xianju Pharmaceutical and Adamerck Grant Aspen China Rights to Aomeikesong Neuromuscular Reversal Agent

Zhendong Pharmaceutical Secures China Promotion Rights to Ferring’s Sodium Picosulfate
CompanyDeals

Zhendong Pharmaceutical Secures China Promotion Rights to Ferring’s Sodium Picosulfate

CompanyDeals

GenAssist Therapeutic Partners with Indian DART Foundation on Duchenne Muscular Dystrophy Base Editing

CompanyDeals

Foresee Pharmaceuticals Licenses MMP-12 Inhibitor Portfolio to Primevera for $584.5 Million

CompanyDeals

Formosa Pharmaceuticals Licenses APP13007 Eye Drops to Samil Pharma for South Korea Market

CompanyDeals

Nanjing Hanxin Licenses AC02 ACTH Analogue to Amphastar for $151 Million US/Canada Deal

CompanyDeals

Chia Tai Fenghai Licenses FHND5032 miR-124 Inducer to Formation Bio for $500 Million

CompanyDeals

Henlius Biotech Secures Global Rights to U-mab’s IL-1RAP Antibody in Licensing Deal